39 results on '"Åsberg, Anders"'
Search Results
2. Clinical performance of volumetric finger‐prick sampling for the monitoring of tacrolimus, creatinine and haemoglobin in kidney transplant recipients
3. Optimizing medication adherence with home‐monitoring – A feasibility study using capillary microsampling and mHealth in solid organ‐transplanted adolescents
4. Cysteine‐lowering treatment with mesna against obesity: Proof of concept and results from a human phase I, dose‐finding study
5. Impact of type 2 diabetes on in vivo activities and protein expressions of cytochrome P450 in patients with obesity
6. Anticoagulation and safety of renal transplant biopsy
7. Short‐ and long‐term effects of body weight, calorie restriction and gastric bypass on CYP1A2, CYP2C19 and CYP2C9 activity
8. Drug Disposition Protein Quantification in Matched Human Jejunum and Liver From Donors With Obesity
9. A single Bayesian estimator for iohexol clearance estimation in ICU, liver failure and renal transplant patients
10. Atorvastatin population pharmacokinetics in a real‐life setting: Influence of genetic polymorphisms and association with clinical response
11. Short‐ and long‐term effects of body weight loss following calorie restriction and gastric bypass on CYP3A‐activity – a non‐randomized three‐armed controlled trial
12. Increased systemic exposure of once‐daily tacrolimus in renal transplant recipients on marine omega‐3 fatty acid supplementation
13. Proteomics‐Informed Prediction of Rosuvastatin Plasma Profiles in Patients With a Wide Range of Body Weight
14. Fasting Status and Circadian Variation Must be Considered When Performing AUC‐based Therapeutic Drug Monitoring of Tacrolimus in Renal Transplant Recipients
15. Five decades with grandparent donors: The Norwegian strategy and experience
16. Chronic Inhibition of CYP3A is Temporarily Reduced by Each Hemodialysis Session in Patients With End‐Stage Renal Disease
17. Endothelial function after pancreas transplantation—A single‐center observational study
18. Reply to letter: “What about drug bioavailability in patients who had bariatric surgery and dependent on immunosuppressives?”
19. The influence of bariatric surgery on oral drug bioavailability in patients with obesity: A systematic review
20. Why dose adjust systemic exposure when looking for associations with adverse events in tacrolimus‐treated transplant recipients?
21. Vitamin D as a risk factor for patient survival after kidney transplantation: A prospective observational cohort study
22. Pharmacokinetics of a novel, approved, 1.4‐mg intranasal naloxone formulation for reversal of opioid overdose—a randomized controlled trial
23. High tacrolimus clearance - a risk factor for development of interstitial fibrosis and tubular atrophy in the transplanted kidney: a retrospective single-center cohort study
24. Arterial stiffness is associated with visceral fat mass in kidney transplanted patients-A nationwide cohort study
25. Small effort, high impact: Focus on physical activity improves oxygen uptake (VO2peak ), quality of life, and mental health after pediatric renal transplantation
26. Kidney allograft subclinical rejection modulates systemic inflammation measured by C-reactive protein at 1 year after transplantation
27. A rapid and sustained improvement of calcification propensity score (serum T50 ) after successful kidney transplantation: Reanalysis of a randomized controlled trial of ibandronate
28. Response to: ‘Response to: Bodyweight-adjustments introduce significant correlations between CYP3A metrics and tacrolimus clearance’
29. The CYP3A biomarker 4β‐hydroxycholesterol does not improve tacrolimus dose predictions early after kidney transplantation
30. Bodyweight-adjustments introduce significant correlations between CYP3A metrics and tacrolimus clearance
31. Visceral fat is strongly associated with post-transplant diabetes mellitus and glucose metabolism 1 year after kidney transplantation
32. Low-target tacrolimus in de novo standard risk renal transplant recipients: A single-centre experience
33. The Mortality Associated With Chronic Widespread Musculoskeletal Complaints: A Systematic Review of the Literature
34. Uric acid and clinical correlates of endothelial function in kidney transplant recipients
35. Improved prediction of tacrolimus concentrations early after kidney transplantation using theory‐based pharmacokinetic modelling
36. 2-D hydrophilic interaction liquid chromatography-RP separation in urinary proteomics - Minimizing variability through improved downstream workflow compatibility
37. Calcineurin inhibitor effects on glucose metabolism and endothelial function following renal transplantation
38. Fluvastatin reduces atherogenic lipids without any effect on native endothelial function early after kidney transplantation
39. Proteomics-Informed Prediction of Rosuvastatin Plasma Profiles in Patients With a Wide Range of Body Weight.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.